Rivaroxaban Adco 10 mg Film-Coated Tablets

    Rivaroxaban Adco 10 mg Film-Coated Tablets

    S4

    API: Rivaroxaban | Company: Adcock Ingram

    1. What RIVAROXABAN ADCO is and what it is used for

    RIVAROXABAN ADCO contains the active substance rivaroxaban. It belongs to a group of medicines called antithrombotic medicines. It works by blocking a blood clotting factor (factor Xa) and thus reducing the tendency of the blood to form clots.

    RIVAROXABAN ADCO 10 is used in adults to:

    • prevent blood clots in the veins after a major surgery in your lower limbs. Your doctor has prescribed this medicine for you because after an operation you are at an increased risk of getting blood clots.

    RIVAROXABAN ADCO 15 and 20 are used in adults to:

    • prevent blood clots in the brain (stroke) and other blood vessels in your body if you have a form of irregular heart rhythm called non-valvular atrial fibrillation.
    • treat blood clots in the veins of your legs (deep vein thrombosis) and in the blood vessels of your lungs (pulmonary embolism), and to prevent blood clots from recurring in the blood vessels of your legs and/or lungs.

    2. What you need to know before you take RIVAROXABAN ADCO

    Do not take RIVAROXABAN ADCO:

    • if you are hypersensitive (allergic) to rivaroxaban or any of the other ingredients of RIVAROXABAN ADCO (see What RIVAROXABAN ADCO contains).
    • if you have a tendency of bleeding excessively.
    • if you have a disease or condition in an organ of the body that increases the risk of serious bleeding (e.g. stomach ulcer, injury or bleeding in the brain, recent surgery of the brain or eyes).
    • if you are taking medicines to prevent blood clotting (e.g. warfarin or heparin), except when changing anticoagulant treatment or while getting heparin through a venous or arterial line to keep it open.
    • if you have a liver disease which leads to an increased risk of bleeding.
    • if you are pregnant or breast feeding.

    Warnings and precautions

    Take special care with RIVAROXABAN ADCO:

    • if you have an increased risk of bleeding, as could be the case in situations such as:
      • severe kidney disease, since your kidney function may affect the amount of medicine that works in your body.
      • bleeding disorders.
      • very high blood pressure, not controlled by medical treatment.
      • diseases of your stomach or bowel that might result in bleeding, e.g. inflammation of the bowels or stomach, or inflammation of the oesophagus (gullet) e.g. due to gastroesophageal reflux disease (disease where stomach acid goes upwards into the oesophagus).
      • a problem with the blood vessels in the back of your eyes (retinopathy).
      • recent bleeding in your brain (intracranial or intracerebral bleeding).
      • a recent operation on your brain, spinal column or eye.
      • if you have a lung disease called bronchiectasis. Bronchiectasis is a disease in which there is a permanent enlargement of parts of the airways of the lung. Symptoms typically include a chronic cough with mucus production. Other symptoms include shortness of breath, coughing up blood, and chest pain.
      • previous bleeding from your lung.
      • if you have a prosthetic heart valve.

    If any of the above applies to you, tell your doctor before you take RIVAROXABAN ADCO. Your doctor will decide, if you should be treated with RIVAROXABAN ADCO and if you should be kept under close observation.

    If you need to have an operation:

    • it is very important to take RIVAROXABAN ADCO before and after the operation exactly at the times you have been told by your doctor.
    • If your operation involves a catheter or injection into your spinal column (e.g. for epidural or spinal anaesthesia or pain reduction):
      • it is very important to take RIVAROXABAN ADCO before and after the injection or removal of the catheter exactly at the times you have been told by your doctor.
      • tell your doctor immediately if you get numbness or weakness of your legs or problems with your bowel or bladder after the end of anaesthesia, because urgent care is necessary.

    Children and adolescents:

    Do not give RIVAROXABAN ADCO to people under 18 years of age.

    Other medicines and RIVAROXABAN ADCO:

    Always tell your healthcare professional if you are taking any other medicine. (This includes complementary or traditional medicines.)

    Tell your doctor or pharmacist if you are taking:

    The following medicines that can enhance the effect of RIVAROXABAN ADCO and lead to increase in bleeding risk:

    • some medicines for fungal infections (e.g. ketoconazole, itraconazole, voriconazole, posaconazole), unless they are only applied to the skin;
    • ketoconazole tablets (used to treat Cushing’s syndrome – a medical condition where your body produces an excess of cortisol) as it may enhance the effect of;
    • some anti-viral medicines for HIV / AIDS (e.g. ritonavir);

    3. How to take RIVAROXABAN ADCO

    Do not share medicines prescribed for you with any other person. Always take RIVAROXABAN ADCO exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.

    RIVAROXABAN ADCO 10:

    The usual dose is: The recommended dose is one 10 mg tablet once a day.

    When to take RIVAROXABAN ADCO 10:

    Take the first tablet 6 – 10 hours after your operation. Then take a tablet every day until your doctor tells you to stop. Try to take the tablet at the same time every day to help you to remember it. If you have had a major hip operation you will usually take the tablets for 5 weeks.

    If you have had a major knee operation you will usually take the tablets for 2 weeks.

    RIVAROXABAN ADCO 15 and RIVAROXABAN ADCO 20:

    The usual dose is:

    • To prevent blood clots in brain (stroke) and other blood vessels in your body - the recommended dose is one 20 mg tablet once a day. If you have kidney problems, the dose may be reduced to one 15 mg tablet once a day.
    • To treat blood clots in the veins of your legs and blood clots in the blood vessels of your lungs, and for preventing blood clots from re-occurring - the recommended dose is one 15 mg tablet twice a day for the first 3 weeks. For treatment after 3 weeks, the recommended dose is one 20 mg tablet once a day. If you have kidney problems, your doctor may decide to reduce the dose for the treatment after 3 weeks to one 15 mg tablet once a day if the risk for bleeding is greater than the risk for having another blood clot.

    Your doctor will tell you how long your treatment with RIVAROXABAN ADCO will last. Do not stop treatment early. If you have the impression that the effect of RIVAROXABAN ADCO is too strong or too weak, tell your doctor or pharmacist.

    Use in children and adolescents

    RIVAROXABAN ADCO should not be given to children or adolescents under 18 years.

    If you take more RIVAROXABAN ADCO than you should:

    In the event of overdosage, consult your doctor or pharmacist. If neither is available, contact the nearest hospital or poison control centre.

    If you forget to take RIVAROXABAN ADCO:

    RIVAROXABAN ADCO 10

    If you are taking one 10 mg tablet once a day and have missed a dose, take it as soon as you remember. Do not take more than one tablet in a single day to make up for a forgotten dose. Take the next tablet on the following day and then carry on taking one tablet once a day.

    RIVAROXABAN ADCO 15

    If you are taking one RIVAROXABAN ADCO 15 mg tablet twice a day and have missed a dose, take it as soon as you remember. Do not take more than two 15 mg tablets in a single day. If you forget to take a dose you can take two 15 mg tablets at the same time to get a total of two tablets (30 mg) on one day. On the following day you should carry on taking one 15 mg tablet twice a day.

    RIVAROXABAN ADCO 20

    If you are taking one 20 mg tablet once a day and have missed a dose, take it as soon as you remember. Do not take more than one tablet in a single day to make up for a forgotten dose. Take the next tablet on the following day and then carry on taking one tablet once a day.

    4. Possible side effects

    RIVAROXABAN ADCO can have side effects. Not all side effects reported for RIVAROXABAN ADCO are included in this leaflet. Should your general health worsen or if you experience any untoward effects while taking RIVAROXABAN ADCO, please consult your health care provider for advice.

    RIVAROXABAN ADCO may cause bleeding which may potentially be life threatening. Excessive bleeding may lead to a sudden drop in blood pressure (shock). In some cases the bleeding may not be obvious.

    Possible side effects which may be a sign of bleeding: Tell your doctor immediately if you experience any of the following side effects:

    • long or excessive bleeding
    • exceptional weakness, tiredness, paleness, dizziness, headache, unexplained swelling, breathlessness, chest pain or angina pectoris, which may be signs of bleeding.

    Your doctor may decide to keep you under close observation or change how you should be treated.

    Side effects which may be experienced frequently:

    • reduction in red blood cells which can make the skin pale and cause weakness or breathlessness;
    • headache, dizziness;
    • bleeding into the eye (including bleeding from the whites of the eyes);
    • low blood pressure (symptoms may be feeling dizzy or fainting when standing up), bleeding into a cavity of the body (haematoma, bruising);
    • nose bleeds and coughing up blood;
    • bleeding in the stomach or bowel, bleeding from the rectum, stomach pains, bleeding in the gum;
    • nausea, constipation, diarrhoea, vomiting;
    • blood tests may show an increase in some liver enzymes;
    • rash, itchy skin;
    • bleeding from the skin or under the skin;
    • pain in the limbs;
    • bleeding from genitals (including passing blood in the urine and heavy menstrual bleeding);
    • fever, decreased general strength and energy (weakness, tiredness), swelling in the limbs;
    • bleeding following an operation, oozing of blood from surgical wound;

    Side effects which may be experienced less frequent:

    • RIVAROXABAN ADCO 10
    • decrease in platelets (substances that help the blood to clot) in your blood;
    • allergic reactions, including allergic skin reactions;
    • bleeding into the brain or inside the skull, loss of consciousness caused by a fall in blood pressure;
    • fast heartbeat;
    • dry mouth;
    • impaired function of the liver and jaundice;
    • impaired function of the liver (may be seen in tests performed by your doctor);
    • severe skin rash on the skin and in mucosal lining (like in the mouth) with sever blistering accompanied by fever;
    • bleeding into a muscle, compartment syndrome (swelling of a limb) caused by bleeding into the tissue or muscle;
    • impaired function of the kidneys (may be seen in tests performed by your doctor);
    • localised swelling, fever, feeling unwell;
    • blood tests may show an increase in some pancreatic or liver enzymes;
    • false aneurysm (a collection of blood that forms between the two outer layers of an artery).

    If you notice any side effects not mentioned in this leaflet, please inform your doctor or pharmacist.

    Reporting of side effects

    If you get side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects to SAHPRA via the 6.04 Adverse Drug Reaction Reporting Form, found online under SAHPRA’s publications https://www.sahpra.org.za/Publications/Index/8. By reporting side effects, you can help provide more information on the safety of RIVAROXABAN ADCO.

    5. How to store RIVAROXABAN ADCO

    • Store all medicines out of reach of children.

    • Store at or below 30 °C.

    • Keep blister strips in the outer carton until required for use.

    • Do not use after the expiry date printed on the carton.

    • Return all unused medicine to your pharmacist.

    • Do not dispose of unused medicine in drains or sewerage systems (e.g. toilets).

    Important Disclaimer

    The Rivaroxaban Adco 10 mg Film-Coated Tablets professional information leaflet below is the property of Adcock Ingram and is provided on Somayeza exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Somayeza serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>

    Unlock Exclusive Features

    To ensure the fastest, most secure experience, this feature is exclusively available on the free Somayeza mobile app.

    Download the App to Unlock
    On This Page
    Rivaroxaban Adco 10 mg Film-Coated Tablets
    1/-
    Official PDF leaflet

    The patient information text is available above. Load the original PDF only when you need it.

    Somayeza AI
    Hello! I am your medical reading assistant. What would you like to know about this patient information leaflet?
    Successfully Stashed! 💊

    This patient information leaflet has been safely stored in your digital medical cabinet. No prescription needed to view it later!

    View My Favourites